Press Сentre
Наши новости
June 27 was the pre-selection day of biobridge 2019 that brought the first on-site event organized to introduce teams and pre-select projects to the acceleration program. During the event, 20 projects across various fields of medicine — oncology, radiology, women’s health, cardiology, etc. — were presented. Those participants who could not attend ...
27.11.2019
Today, on May 31, 2019, the finale of the open competition for development teams and start-ups, which create drug discovery & development solutions using artificial intelligence (AI) technologies, took place at “Boiling Point ASI”. The competition was organized by ChemRar Group together with the Moscow Institute of Physics and Technology and ...
27.11.2019
On May 17, at the Headquarters of the State Hermitage, within the framework of the 9th Saint Petersburg International Legal forum, the 2030 Strategy for Developing the Pharmaceutical Industry of Russia was discussed. The session involved First Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb, CEO of Sintez OJSC Sergey ...
27.11.2019
ChemRar Research Institute invites partners to use the new online form that helps quickly order the individual compound synthesis:
group’s 29-year experience in the contract-based synthesis of small molecules, advanced approaches, and cutting-edge equipment are what help find an optimal solution for your tasks. Get an individual offer from 20+ ...
27.11.2019
Avineuro Project from ChemRar Group and organization Support of Patients with Alzheimer’s Disease and Their Families announced the launch of the educational online platform Memory Help for families of those suffering from dementia. The first group of the online school will start learning on April 25 and finish on June 2, 2019.
Memory Help’s ...
27.11.2019
On April 3, 2019, the first meeting of the NeuroNet team was held at the Ministry of Education and Science of the Russian Federation.
The team’s mission is forming the globally-competitive Russian segment of the NeuroNet market by 2035, ensuring the emergence of at least 10 national “champion companies”. The meeting was hosted by co-executives ...
27.11.2019
On March 14–15, 2019, the key sponsors of the acceleration program BioBridge-2019 — representatives of ChemRar Group and RDI Group — conducted several meetings and negotiations with Austrian partners, including Vienna Business Agency, which provides comprehensive support to companies willing to run business in Austria, and also visited the ...
27.11.2019
ChemRar Group and RDI group with the support of Neuronet industry union announce the launch of the first Russian international acceleration program BioBridge-2019 to support research and development projects for innovative pharmaceuticals and treatment methods. The Accelerator will include a competitive selection of the most advanced ...
27.11.2019
On February 15, 2019, the semester course “Workshops on pharmacy business: How to develop the latest medicine and earn money” will start at the Department of Innovative Pharmaceuticals, Medical Engineering, and Biotechnology at the MIPT School of Biological and Medical Physics. The training course has been organized by the MIPT School of ...
27.11.2019
On June 10–17, 2019, a delegation of leading cardiac surgeons from China officially visited Russia at CardioSystemPharma’s invitation for scientific exchange and establishment of the Russian–Chinese international expert research center for cardiac surgery. The delegation included representatives of the Beijing Cardiac Surgery Center Fuwai, the ...
13.09.2019
On June 29, Vladimir Zelman, the prominent Soviet and American neuroanesthesiologist and head of the Anesthesiology and Intensive Care Department at the clinic of the University of Southern California, visited ChemRar High Tech Center. Professor Zelman is one of the best doctors in the United States and one of the most active supporters of the ...
13.09.2019
CardioSystemPharma company, a subsidiary of ChemRar Group, has introduced a unique Russian innovative cardioplegic drug Normacor® to the leading Chinese cardiosurgeons on the 5th International Forum One Belt One Road: Pudong, which took place on May 16 at Shanghai International Conference Center, China.
Normacor® is intended for advanced cardiac ...
13.09.2019
Публикации в печатных и электронных СМИ
Видео
Фото
